Coinbase CEO Brian Armstrong argues the next economy won't be built for humans — it will be built by machines, and the machines need bank accounts.

OpenAI chief scientist Jakub Pachocki has called for stronger global safeguards - OpenAI’s Jakub Pachocki Warns World Is Not ...

Consensus des Analystes sur Recursion Pharmaceuticals Inc (RXRX), prévisions de cours à 12 mois du consensus, en se basant sur les meilleurs analystes du secteur.

The connected representation of biology those models run on is built once and curated for decades. MindWalk Holdings Corp. is selling the second thing. Twenty years of curation, quantified. HYFT® ...

Why do some groups of organisms contain thousands of species while others have only a handful? Evolutionary biologists have ...

Blood of Dawnwalker reviews land at 83 on Metacritic ahead of the September 3 launch: Rebel Wolves’ debut vampire RPG earns ...

Richard Socher’s The Eureka Machine argues agentic superintelligence could transform science through simulation, integration, ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Recursion's Recursion Operating System combines large-scale biological and chemical datasets, machine learning, ...

This score calculates overall vulnerability severity from 0 to 10 and is based on the Common Vulnerability Scoring System (CVSS). Attack Vector: This metric reflects the context by which vulnerability ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...